Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **dorsomedial prefrontal cortex** (dmPFC) is a subregion of the prefrontal cortex located in the medial aspect of the frontal lobes. It encompasses portions of Brodmann areas 8, 9, 10, 24, and 32[1]. The dmPFC plays key roles in higher-order cognitive functions such as processing self-related information, integrating social impressions and traits (“theory of mind”), moral reasoning, empathy, decision making under uncertainty or stress, emotional regulation (including fear and anxiety), altruism, and top-down inhibition over motor responses[1][2]. It also contributes to long-term memory formation and modulates heart rate during stress or fear[1]. Neuroimaging studies have shown that activity in the dmPFC is associated with forming coherent social impressions by integrating facial cues with verbal descriptions[2]. Functional MRI data suggest that this region is particularly involved in abstract thinking processes rather than simple perception[4]. Animal studies indicate analogous functions related to emotional regulation across species. The **dmPFC** is not a molecule or receptor but rather an anatomical brain region composed primarily of neurons. Therefore it does not fit standard definitions for therapeutic “targets” like receptors or enzymes. While it may be indirectly targeted by neuromodulation techniques such as transcranial magnetic stimulation (TMS) for research or potential therapeutic purposes—especially in neuropsychiatric conditions—it does not have direct interacting drugs nor mechanisms typical for molecular targets. Because this entry refers to a brain region rather than a discrete molecular entity commonly considered as drug targets (such as receptors or enzymes), it should be flagged as "incorrect" if strict molecular targeting conventions are required[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dorsomedial prefrontal cortex (dmPFC).